bazedoxifene has been researched along with arginine in 1 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (arginine) | Trials (arginine) | Recent Studies (post-2010) (arginine) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 46,388 | 1,688 | 11,176 |
| Protein | Taxonomy | bazedoxifene (IC50) | arginine (IC50) |
|---|---|---|---|
| Cationic amino acid transporter 3 | Homo sapiens (human) | 283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, S; Kida, Y; Marumo, K; Nishizawa, T; Okabe, H; Saito, M; Seki, A | 1 |
1 other study(ies) available for bazedoxifene and arginine
| Article | Year |
|---|---|
Effects of 18-month treatment with bazedoxifene on enzymatic immature and mature cross-links and non-enzymatic advanced glycation end products, mineralization, and trabecular microarchitecture of vertebra in ovariectomized monkeys.
Topics: Animals; Arginine; Bone Density; Bone Density Conservation Agents; Collagen; Cross-Linking Reagents; Disease Models, Animal; Female; Glycation End Products, Advanced; Humans; Indoles; Lumbar Vertebrae; Lysine; Macaca fascicularis; Osteoporosis, Postmenopausal; Ovariectomy; Selective Estrogen Receptor Modulators; X-Ray Microtomography | 2015 |